Biomedix vascular solution
Biomedix is a privately held healthcare technology company that develops non-invasive PADnet vascular diagnostic devices and the cloud-based Biomedix Xchange population health platform, serving podiatrists, hospitals, health systems, Medicare Advantage Organizations, and value-based care organizations across the United States.
- Company typePrivate
- Founded2004
- HeadquartersSaint Paul, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biomedix vascular solution does
Biomedix, operating through its legal entity Collaborative Care Diagnostics, LLC, is a privately held healthcare technology company headquartered in St. Paul, Minnesota, that has provided front-line diagnostic solutions for vascular disease detection since 2004. The company's core products, PADnet and PADnet Xpress, are non-invasive vascular assessment systems that use air cuff and photoplethysmography (PPG) probe technology to measure Ankle-Brachial Index (ABI), Toe-Brachial Index (TBI), Segmental Pressure values, and Pulse Volume Recording (PVR) waveforms for identifying peripheral artery disease (PAD) and chronic venous insufficiency (CVI). PADnet Xpress, a portable mobile device capable of completing tests in under 2 minutes, received FDA clearance for home use in November 2022 and expanded to Android in December 2024. The company also offers integrated third-party diagnostic modules including BeamMed MiniOmni for osteoporosis screening, IRIS for diabetic retinopathy, NDD Medical Spirometry for COPD, and NeuroMetrix DPNCheck for peripheral neuropathy.
The Biomedix Xchange platform serves as the central cloud-based, HITRUST CSF-certified population health management hub that aggregates diagnostic data from multiple modalities into a single patient encounter, supports bi-directional EMR/CRM integration, and enables SDoH data collection. Biomedix generates revenue through a hybrid model combining one-time device sales (PADnet hardware, integrated third-party diagnostic devices) with what appears to be recurring SaaS subscription revenue from the Biomedix Xchange platform. The company operates exclusively in the United States and sells through enterprise field sales, channel partner SureFit, and direct website inquiry, targeting podiatrists, hospitals, health systems, Medicare Advantage Organizations, and value-based care organizations. The company is led by CEO John Romans, VP of Product Chris Trygstad, and VP of Customer Success and Growth Jesse Moore, and has no disclosed external funding rounds or institutional investor backing.
Biomedix vascular solution firmographics
Firmographics- Name
- Biomedix vascular solution
- Legal name
- Collaborative Care Diagnostics, LLC
- Website
- https://biomedix.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Biomedix is a privately held healthcare technology company that develops non-invasive PADnet vascular diagnostic devices and the cloud-based Biomedix Xchange population health platform, serving podiatrists, hospitals, health systems, Medicare Advantage Organizations, and value-based care organizations across the United States.
- Ownership category
- akta.pro rank
Biomedix vascular solution industry classification
Industry- Product category
- Vascular Diagnostic Devices & Population Health Platform
- NAICS
- Ambulatory Health Care Services (621)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL)
- akta.pro secondary industries
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), RPM Reimbursement, Billing & Program Operations Platforms (HLACAFAN)
Keywords
Where Biomedix vascular solution is headquartered
LocationHeadquarters
- HQ city
- Saint Paul
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Biomedix vascular solution business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Revenue model
- Medical Diagnostic Devices: Sale of PADnet vascular assessment systems, PADnet Xpress mobile screening devices, and related diagnostic hardware. Devices are sold to healthcare providers, hospitals, and health systems for point-of-care testing.
- Biomedix Xchange SaaS Platform: Cloud-based population health management platform that aggregates diagnostic data. Likely operates on subscription model for ongoing platform access, data storage, and support services.
- Integrated Third-Party Diagnostic Devices: Revenue from integrated diagnostic devices including BeamMed MiniOmni (osteoporosis), IRIS fundus camera (diabetic retinopathy), NDD Medical Spirometers (COPD), and NeuroMetrix DPNCheck (peripheral neuropathy) hosted on the Biomedix technology stack.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing for healthcare organizations |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
Biomedix vascular solution product offering
Product offeringCore offering
Biomedix manufactures and sells non-invasive point-of-care diagnostic devices—primarily the PADnet and PADnet Xpress systems for detecting peripheral artery disease (PAD) and chronic venous insufficiency (CVI)—and operates the Biomedix Xchange cloud-based population health management platform that aggregates diagnostic data from multiple modalities for healthcare providers, hospitals, health systems, and Medicare Advantage Organizations.
Product overview
Biomedix offers a portfolio of point-of-care diagnostic devices integrated through the Biomedix Xchange population health management platform. The core products include PADnet and PADnet Xpress for peripheral artery disease (PAD) and chronic venous insufficiency (CVI) testing, along with integrated diagnostic modules including BeamMed MiniOmni for bone density/osteoporosis screening, IRIS for diabetic retinopathy screening, NDD Medical Spirometry for COPD testing, and NeuroMetrix DPNCheck for peripheral neuropathy detection. The Biomedix Xchange platform serves as the central hub that aggregates data from multiple diagnostic modalities, enabling coordinated care and population health analysis across chronic conditions for value-based care organizations.
Differentiator
Problem solved
Functional benefit
Brands
- PADnet: Flexible and customizable vascular assessment system designed to identify peripheral artery disease (PAD) and chronic venous insufficiency (CVI) through non-invasive physiologic testing.
- PADnet Xpress
- Biomedix Xchange
- MiniOmni
Products and services
- PADnet A flexible and customizable vascular assessment system designed to identify hidden peripheral vascular disease through non-invasive physiologic testing in clinical settings. Uses air cuff and PPG probe technology to record ABI, TBI, segmental pressures, and PVR waveforms; also supports venous refill studies for CVI testing. Sold to healthcare providers, hospitals, and health systems.
- PADnet Xpress A portable, mobile PAD screening device designed for population health management with tests performed in under 2 minutes using a single-page user interface and live signal quality feedback. HITRUST-certified with electrical safety testing for home use per 60601-1-11 standards. Available as a mobile app on Apple App Store and Google Play.
- Biomedix Xchange A web-based population health management platform designed to combine results from multiple diagnostic tests onto a single platform. Enables value-based care organizations to coordinate care through an integrated technology stack that identifies multiple chronic conditions and behavioral health information, with bi-directional EMR/CRM integration and SDoH data collection via digital questionnaires.
- BeamMed MiniOmni
Quantifiable outcome
- Podiatric services reduce hospitalizations related to obesity by 19% and diabetes by 37%
- +5 more outcomes
Companies that use Biomedix vascular solution
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles3 records
Biomedix vascular solution technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature6 records
Biomedix vascular solution partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- New York College of Podiatric Medicine (NYCPM)coreDonation of PADnet 5th generation device, PADnet Xpress, and digital health assessments for integration into educational and clinical training programs. Supports both student clinical training and research in vascular health, positioning NYCPM as a leader in podiatric education.
- Memorial Sloan Kettering Cancer Center (MSKCC)coreResearch partnership with world-leading cancer center to screen for PAD in cancer patients undergoing surgery. Dr. Yolanda Bryce, MD serves as Principal Investigator. Study uses PADnet technology to discover PAD prevalence in cancer patients and compare outcomes between cancer patients with and without PAD. Research aims to investigate racial disparities in PAD and amputation rates.
- Healthcare Provider EMR/CRM SystemscoreBiomedix Xchange offers bi-directional interface for automated integration with customer and stakeholder EMRs, CRMs, and other systems of record. Enables healthcare organizations to aggregate diagnostic data with existing IT infrastructure.
- Western University of Health Sciences College of Podiatric MedicinecoreClinical and educational sponsorship with WesternU College of Podiatric Medicine. Donation of advanced diagnostic technology to enhance education in podiatric medicine, supporting hands-on training with latest medical devices and techniques.
- SureFitcoreLong-standing channel partnership where SureFit distributes PADnet products through booths at major podiatry and vascular conferences including APMA, AAPPM, Western Foot and Ankle Conference, DERMfoot, and Region Three. SureFit handles regional distribution and promotional activities at trade shows.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Biomedix vascular solution competitors and assessment
Company assessmentDirect peers
- Huntleigh Diagnostics: Huntleigh Diagnostics (part of Arjo) manufactures non-invasive vascular assessment equipment (Doppler, ABI/TBI systems) used in clinical settings. It directly overlaps with Biomedix's PADnet on vascular diagnostic capability, target clinician base (podiatry/vascular/PCP), and physiologic-test methodology.
- Perimed: Perimed is a Swedish maker of non-invasive vascular and microcirculation diagnostic instruments used to assess peripheral circulation. Its product set and clinical use cases (PAD/peripheral vascular assessment in office-based settings) closely mirror PADnet's value proposition, making it a direct peer.
- Itamar Medical: Itamar Medical (acquired by ZOLL/Asahi Kasei) develops non-invasive peripheral vascular diagnostics (EndoPAT platform) targeting cardiometabolic and cardiovascular risk assessment. It overlaps with Biomedix in point-of-care vascular endpoints sold to cardiology and primary-care clinicians.
- Atcor Medical (USCOM): Atcor Medical (now part of USCOM) developed non-invasive cardiovascular diagnostic devices, including central blood pressure and PWA/PVR-style measurements, used in vascular and primary-care assessments. It overlaps directly with PADnet's non-invasive physiologic testing approach.
Broad incumbents
- Welch Allyn (Baxter): Welch Allyn (now part of Baxter) produces a broad portfolio of frontline diagnostic devices including vital-sign and vascular assessment tools sold to clinics and hospitals. It overlaps on primary-care point-of-care vascular testing devices (e.g., ABI systems) but operates as a multi-product incumbent rather than a PAD-focused specialist.
- Hologic: Hologic sells bone densitometry (osteoporosis screening) and women's-health diagnostics — directly comparable to Biomedix's MiniOmni-based osteoporosis screening module and the broader women's vascular screening market (e.g., PAD in women, retinopathy). Hologic operates at much greater scale across a broader diagnostic portfolio.
- GE HealthCare: GE HealthCare offers a broad portfolio of non-invasive vascular and population-health imaging/diagnostic solutions (including ABI-capable peripherals and enterprise cardiology platforms). While not focused narrowly on PAD, it covers adjacent diagnostics and integrated data platforms sold into the same hospital and health-system accounts.
Emerging players
- NeuroMetrix: NeuroMetrix makes the DPNCheck device for peripheral neuropathy (sural nerve conduction) which is integrated into the Biomedix Xchange platform. It overlaps on the multi-modality chronic-care screening footprint and clinician channels (podiatry, primary care).
- Vivify Health (Optum): Vivify Health (acquired by Optum) offers an RPM and patient-engagement platform used by health plans and value-based-care providers. It competes for the same MAO and value-based-care budgets that Biomedix targets, though its strength is mobile RPM pathways rather than point-of-care diagnostics.
- Health Recovery Solutions (HRS): HRS provides a connected-health/RPM platform with condition-specific pathways for chronic disease management. It overlaps with Biomedix Xchange on value-based-care chronic-condition workflows and payer/MA procurement channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biomedix vascular solution social profiles
Digital presenceBiomedix vascular solution compliance and trust
Trust signalCompliance2 records
Biomedix vascular solution financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biomedix vascular solution leadership team
Management profileNumber of profiles
Profiles3 records
Biomedix vascular solution funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biomedix vascular solution M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biomedix vascular solution
What does Biomedix vascular solution do?
Biomedix manufactures and sells non-invasive point-of-care diagnostic devices—primarily the PADnet and PADnet Xpress systems for detecting peripheral artery disease (PAD) and chronic venous insufficiency (CVI)—and operates the Biomedix Xchange cloud-based population health management platform that aggregates diagnostic data from multiple modalities for healthcare providers, hospitals, health systems, and Medicare Advantage Organizations.
Is Biomedix vascular solution a public or private company?
Biomedix vascular solution is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Biomedix vascular solution founded?
Biomedix vascular solution was founded in 2004. It employs 51 to 100 people.
Where is Biomedix vascular solution based?
Biomedix vascular solution is headquartered in Saint Paul, United States, in the North America region.
How does Biomedix vascular solution make money?
Three revenue lines are on record. Medical Diagnostic Devices are the primary driver. The others are biomedix Xchange SaaS Platform and integrated Third-Party Diagnostic Devices.
Who are Biomedix vascular solution's main competitors?
Direct peers on record are Huntleigh Diagnostics, Perimed, Itamar Medical and Atcor Medical (USCOM). Broad incumbents are Welch Allyn (Baxter), Hologic and GE HealthCare. Emerging players are NeuroMetrix, Vivify Health (Optum) and Health Recovery Solutions (HRS).
Does Biomedix vascular solution have an API?
No public API is recorded for Biomedix vascular solution.
What industry is Biomedix vascular solution in?
Biomedix vascular solution's product category is Vascular Diagnostic Devices & Population Health Platform. Its primary akta.pro industry code is HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 621 and its SIC code is 3841.